Literature DB >> 1952449

Disseminated tuberculosis in the acquired immunodeficiency syndrome era.

A R Hill1, S Premkumar, S Brustein, K Vaidya, S Powell, P W Li, B Suster.   

Abstract

To assess the influence of human immunodeficiency virus type 1 (HIV)-induced immunodeficiency on the clinical, radiographic, and pathologic features of disseminated tuberculosis (TB), we studied 79 patients presenting in 1984 through 1987 with miliary or focal disseminated disease due to Mycobacterium tuberculosis, as well as 4 additional non-HIV patients diagnosed after 1987. Clinically defined acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) was present in 51 (Group 1). A total of 20 had TB unrelated to HIV disease (Group 2). The remaining 12 were excluded because the role of HIV could not be determined. Clinical features were similar between groups aside from younger age; lower hemoglobin, total leukocyte, lymphocyte, and platelet counts; and more frequent tuberculin anergy (90 versus 40%) in AIDS/ARC patients (p less than or equal to 0.03). Chest radiographs showed a miliary pattern in about half of each group. Pleural effusion occurred only in AIDS/ARC patients (24%, p = 0.02), but intrathoracic lymphadenopathy was present in about a third of each group. Tissue biopsies (n = 70) usually revealed necrotizing granulomatous inflammation in each group, with a tendency to greater necrosis and more numerous acid-fast bacilli in Group 1. Granulomas were usually poorly formed in AIDS/ARC patients (59 versus 18%, p = 0.01). Autopsy of 9 AIDS/ARC patients with overwhelming miliary TB revealed a "nonreactive" histologic pattern with poorly organized or absent granulomas, extensive necrosis, and numerous bacilli. HIV-related disseminated TB causes a major constitutional illness with a high short-term mortality (25%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1952449     DOI: 10.1164/ajrccm/144.5.1164

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

2.  Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence.

Authors:  R J North; L Ryan; R LaCource; T Mogues; M E Goodrich
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Miliary tuberculosis: a comparison of CT findings in HIV-seropositive and HIV-seronegative patients.

Authors:  J Y Kim; Y J Jeong; K-I Kim; I S Lee; H K Park; Y D Kim; H Seok I
Journal:  Br J Radiol       Date:  2010-03       Impact factor: 3.039

4.  Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.

Authors:  Y Zhang; K Nakata; M Weiden; W N Rom
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Automatic screening for tuberculosis in chest radiographs: a survey.

Authors:  Stefan Jaeger; Alexandros Karargyris; Sema Candemir; Jenifer Siegelman; Les Folio; Sameer Antani; George Thoma
Journal:  Quant Imaging Med Surg       Date:  2013-04

7.  Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B.

Authors:  Y Zhang; M Broser; W N Rom
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology.

Authors:  S Ehlers; J Benini; H D Held; C Roeck; G Alber; S Uhlig
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

9.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

Review 10.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.